Palatin Technologies, Inc. Stock Nyse
Equities
PTN
US6960773041
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Financials (USD)
Sales 2024 * | 4.29M | Sales 2025 * | 7.48M | Capitalization | 28.88M |
---|---|---|---|---|---|
Net income 2024 * | -27M | Net income 2025 * | -21M | EV / Sales 2024 * | 6.73 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.86 x |
P/E ratio 2024 * |
-1.08
x | P/E ratio 2025 * |
-1.86
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.63% |
Latest transcript on Palatin Technologies, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Carl Spana
FOU | Founder | 61 | 86-11-20 |
Stephen Wills
DFI | Director of Finance/CFO | 67 | 96-12-31 |
John Dodd
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
John Prendergast
FOU | Founder | 70 | 86-11-20 |
Carl Spana
FOU | Founder | 61 | 86-11-20 |
Robert deVeer
BRD | Director/Board Member | 78 | 98-10-31 |
1st Jan change | Capi. | |
---|---|---|
-3.25% | 102B | |
+1.68% | 96.29B | |
+2.13% | 22.18B | |
-15.71% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.74% | 16.36B | |
+5.82% | 13.97B | |
+33.88% | 12.17B |
- Stock Market
- Equities
- PTN Stock
- PTN Stock